Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decapeptyl SR subcutaneous injection in prostate cancer
ISRCTN02365168Phase 2Completed
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Dec 2007
- Modality
- Small Molecules, Peptides
01
Overview
Phase 2, open-label, single-arm trial of triptorelin in prostate cancer (PCa), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Serum testosterone suppression at 4 months. Started Dec 2007; status: completed.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on ISRCTN02365168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN02365168.